Agimexpharm Pharmaceutical JSC (HSTC:AGP) Other Current Liabilities: ₫0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTC:AGP Agimexpharm Pharmaceutical JSC HSTC:AGP
13 GF Score
Price ₫32,300.00
! 1 Warning Sign
View Full Analysis

What is Agimexpharm Pharmaceutical JSC Other Current Liabilities?

Agimexpharm Pharmaceutical JSC HSTC:AGP 13 Other Current Liabilities is ₫0.00 Mil as of . 20. GuruFocus rates HSTC:AGP with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

Agimexpharm Pharmaceutical JSC's other current liabilities for the quarter that ended in . 20 was ₫0.00 Mil.

Agimexpharm Pharmaceutical JSC Other Current Liabilities Related Terms

Agimexpharm Pharmaceutical JSC Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Agimexpharm Pharmaceutical JSC's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agimexpharm Pharmaceutical JSC Other Current Liabilities Chart

Agimexpharm Pharmaceutical JSC Annual Data
Trend
Other Current Liabilities

Agimexpharm Pharmaceutical JSC Semi-Annual Data
Other Current Liabilities
HSTC:AGP
13GF Score
Agimexpharm Pharmaceutical JSC HSTC:AGP
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Agimexpharm Pharmaceutical JSC Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ₫0.00 Mil mean?
Agimexpharm Pharmaceutical JSC (HSTC:AGP) has a Other Current Liabilities of ₫0.00 Mil as of . 20. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Agimexpharm Pharmaceutical JSC.
Is Agimexpharm Pharmaceutical JSC's Other Current Liabilities too high?
Agimexpharm Pharmaceutical JSC's current Other Current Liabilities is ₫0.00 Mil. Overall, Agimexpharm Pharmaceutical JSC has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Agimexpharm Pharmaceutical JSC's Other Current Liabilities compare to ?
Agimexpharm Pharmaceutical JSC's Other Current Liabilities of ₫0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Agimexpharm Pharmaceutical JSC. Agimexpharm Pharmaceutical JSC's current Other Current Liabilities is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agimexpharm Pharmaceutical JSC stock overvalued right now?
Agimexpharm Pharmaceutical JSC (HSTC:AGP) has a current Other Current Liabilities of ₫0.00 Mil. The current Other Current Liabilities is ₫0.00 Mil. Agimexpharm Pharmaceutical JSC's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Agimexpharm Pharmaceutical JSC (HSTC:AGP), the current Other Current Liabilities is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Agimexpharm Pharmaceutical JSC Business Description

Comparable Companies
Address 27 Nguyen Thai Hoc, My Binh Ward, An Giang Province, Long Xuyen, VNM
Agimexpharm Pharmaceutical JSC is engaged in producing and trading chemical pharmaceuticals and herbal medicines, health supplements, cosmetics, and medical equipment.
13GF Score

Get the complete analysis for HSTC:AGP

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫32,300.00
Price